Atopic Dermatitis Treatment Market

Date: 2016-05

Atopic dermatitis is a chronic skin inflammation that is mostly seen in infants of age 2-3 months and above to children under 5 years of age. However, there are cases of this affecting adults as well. A skin disease that lasts for long, atopic dermatitis is associated with itchiness, redness of skin and cracked skin. While the causes till date remain unknown, it is said that people who have atopic dermatitis tend to develop hay fever and asthma. Atopic dermatitis is believed to be a genetic problem. There is also a common belief that environmental conditions can make potentially susceptible individuals more likely to get atopic dermatitis. Other factors include seasonal allergies, varying humidity levels, extreme climatic conditions and reaction to strong detergents.

Apart from the growing population that is driving the growth of the atopic dermatitis treatment market, factors such as climatic changes and rising pollution levels are also fuelling the growth of this market. A significant amount of research and development efforts by research institutes and pharmaceutical companies alike is leading to the development of new drugs to deal with this condition. The use of biologics and biomarkers in the treatment of atopic dermatitis is one such development. However, time to market stemming from the approval process for new drugs coupled with high prices is inhibiting the growth of the market to a certain extent.

A common course of treatment recommended for atopic dermatitis is usually a bath with luke warm water followed by the application of a moisturizing cream or lotion. In case the symptoms worse, the application of steroid creams are the next course of action along with some medication to lessen the itchiness. Some of the medications used have known side effects and this increases the challenge for treatment of atopic dermatitis since its occurences is more in children under 5 years of age.

Atopic Dermatitis Treatment Market

Of all the currently available treatments available for atopic dermatitis, topical steroids account for the lasrest share of the market.

In terms of type of treatment, the Atopic Dermatitis Treatment market has been segmented across the following
Topical Corticosteroids

The market has been segmented based on the following geographies:
North America
South America
Middle East

Following are just a few of the companies that are operating in the Atopic Dermatitis Treatment market:
Pfizer Inc.
Astellas Pharma
Meda AB
Regeneron Pharmaceuticals Inc


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample